Big Moving Stock chart patterns and volume.

Nasdaq: GOOG BIIB NFLX AMZN IBB TSLA ALXN SLXP AMGN COST BMRN AAPL VRTX CELG GMCR GILD SWKS INTU SBUX
Nyse: IVV LMT SPG GS HUM PXD MMM NOC IBM ANTM BA TWC PANW TMO CI LH PX UNH ZMH
New Highs: BMRN SJM KRFT PKI HXL CCL WWAV ALTR DK WWW OLN HLT SABR FLO INFN RAD

The Hot Industries

Processed & Packaged Goods 2
Food - Major Diversified 2
Lodging 1

The Hot Sectors

Consumer Goods 5
Technology 3
Services 3

Social Buzz

AMRN is headed higher?

AMRN Stock ChartSimilar Stocks: ABBV AZN TEVA ACST GSK ISIS NEPT


AMRN
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Other
Weekly

Employees:

185
Monthly

Website:

http://www.amarincorp.com

AMRN Amarin Corporation plc

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

favicon

Biotech Stocks Technical Study -- Orexigen Therapeutics, Celgene, PDL BioPharma, Amarin, and Synergy Pharma

18 Mar 2015, 7:01 amLONDON, March 18, 2015 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Investor-Edge has initiated coverage on the following equities: Orexigen Therapeutics Inc. (NASDAQ: OREX), Celgene Corporation (NASDAQ: CELG), PDL BioPharma Inc....
favicon

Pre-Market Most Active for Mar 16, 2015 : AMRN, SLXP, TVIX, RDS/B, FXCM, BAC, XIV, QQQ, AAPL, LTM, MT, NOK

16 Mar 2015, 7:37 amPre-Market Most Active for Mar 16, 2015 : AMRN, SLXP, TVIX, RDS/B, FXCM, BAC, XIV, QQQ, AAPL, LTM, MT, NOK
favicon

Amarin up premarket

12 Mar 2015, 6:35 amAmarin (NASDAQ: AMRN ) is up 16% premarket on increased volume. H.C. Wainwright analyst Andrew Fein upgraded the stock to "Buy" with a $10 price target. The consensus analyst rating on the stock is "Hold" with a $6 target.
favicon

Earnings Reaction History: Amarin Corp., 42.9% Follow-Through Indicator, 6.6% Sensitive

3 Mar 2015, 1:25 pmEarnings Reaction History: Amarin Corp., 42.9% Follow-Through Indicator, 6.6% Sensitive
favicon

What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog

2 Mar 2015, 11:00 amGeron Corporation (GERN) is set to report fourth quarter 2014 results on Mar 3 after the market closes.
favicon

Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog

28 Feb 2015, 6:01 pmIntercept Pharmaceuticals, Inc is slated to report its fourth-quarter 2014 results on Mar 2, 2015.
favicon

Will Arena Pharmaceuticals (ARNA) Disappoint on Q4 Earnings? - Analyst Blog

27 Feb 2015, 2:22 pmArena Pharmaceuticals (ARNA) is scheduled to report fourth-quarter 2014 results on Mar 2.
favicon

Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog

27 Feb 2015, 2:18 pmEndo International, Inc. (ENDP) is scheduled to report its fourth-quarter and full-year 2014 results on Mar 2, 2015.
favicon

Will Mylan (MYL) Beat Earnings on New Product Launches? - Analyst Blog

27 Feb 2015, 11:30 amMylan (MYL) is set to report fourth quarter 2014 results on Mar 2 before the market opens.
favicon

Will Stratasys (SSYS) Disappoint this Earnings Season? - Analyst Blog

27 Feb 2015, 9:10 amStratasys Ltd. (SSYS) is set to report fourth-quarter 2014 results on Mar 2.